General

Hanall Biopharma swings to loss in Q2


Hanall Biopharma Co. on Thursday reported its second-quarter net loss of 3.3 billion won (US$2.4 million), shifting from a profit of 7.3 billion won a year earlier.

The company said in a regulatory filing that it posted an operating loss of 3.1 billion won for the April-June period, compared with a profit of 8.1 billion won a year ago. Revenue fell 23.7 percent to 31.6 billion won.

Source: Yonhap News Agency

Text

Distinctively utilize long-term high-impact total linkage whereas high-payoff experiences. Appropriately communicate 24/365.

Calendar

September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30